[go: up one dir, main page]

NO924978D0 - CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES - Google Patents

CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES

Info

Publication number
NO924978D0
NO924978D0 NO924978A NO924978A NO924978D0 NO 924978 D0 NO924978 D0 NO 924978D0 NO 924978 A NO924978 A NO 924978A NO 924978 A NO924978 A NO 924978A NO 924978 D0 NO924978 D0 NO 924978D0
Authority
NO
Norway
Prior art keywords
naftyridon
chinolon
carboxylic acid
acid derivatives
derivatives
Prior art date
Application number
NO924978A
Other languages
Norwegian (no)
Other versions
NO924978L (en
NO301420B1 (en
Inventor
Uwe Petersen
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Klaus-Dieter Bremm
Rainer Endermann
Karl-Georg Metzger
Ingo Haller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27203290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO924978(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4200414A external-priority patent/DE4200414A1/en
Priority claimed from DE4208792A external-priority patent/DE4208792A1/en
Priority claimed from DE4208789A external-priority patent/DE4208789A1/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO924978D0 publication Critical patent/NO924978D0/en
Publication of NO924978L publication Critical patent/NO924978L/en
Publication of NO301420B1 publication Critical patent/NO301420B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO924978A 1992-01-10 1992-12-22 Quinolone and naphthyridone carboxylic acid derivatives and their use NO301420B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4200414A DE4200414A1 (en) 1992-01-10 1992-01-10 New quinoline and naphthyridinone-carboxylic acid derivs.
DE4208792A DE4208792A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.
DE4208789A DE4208789A1 (en) 1992-03-19 1992-03-19 New quinoline and naphthyridinone-carboxylic acid derivs.

Publications (3)

Publication Number Publication Date
NO924978D0 true NO924978D0 (en) 1992-12-22
NO924978L NO924978L (en) 1993-07-12
NO301420B1 NO301420B1 (en) 1997-10-27

Family

ID=27203290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924978A NO301420B1 (en) 1992-01-10 1992-12-22 Quinolone and naphthyridone carboxylic acid derivatives and their use

Country Status (16)

Country Link
EP (1) EP0550903A1 (en)
JP (3) JPH05271229A (en)
KR (1) KR100251886B1 (en)
CN (3) CN1043142C (en)
AU (1) AU669502B2 (en)
CA (1) CA2086914C (en)
CZ (1) CZ289076B6 (en)
FI (3) FI104174B1 (en)
HU (1) HU219488B (en)
MX (1) MX9207604A (en)
MY (1) MY115416A (en)
NO (1) NO301420B1 (en)
NZ (1) NZ245640A (en)
PL (1) PL174853B1 (en)
SK (3) SK282971B6 (en)
TW (1) TW209865B (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04445A (en) 1990-04-17 1992-01-06 Fuji Photo Film Co Ltd Processing method for silver halide color photosensitive material
EP0720049B1 (en) 1990-05-09 1999-08-04 Fuji Photo Film Co., Ltd. Photographic processing composition and processing method using the same
DE4121214A1 (en) * 1991-06-27 1993-01-14 Bayer Ag 7-AZAISOINDOLINYL CHINOLONE AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
DE4301246A1 (en) * 1993-01-19 1994-07-21 Bayer Ag Quinolone and naphthyridonecarboxylic acid derivatives
JP3372994B2 (en) 1993-06-11 2003-02-04 富士写真フイルム株式会社 Processing method of silver halide color photographic light-sensitive material
DE4329600A1 (en) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d, e] [1,3,4] benzoxadiazine derivatives
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
DE4342186A1 (en) * 1993-12-10 1995-06-14 Bayer Ag One-pot process for the production of 3-quinolonecarboxylic acid derivatives
DE4418510A1 (en) * 1994-05-27 1995-11-30 Bayer Ag 1,9-bridged thiazolol [3,4-a] quinoline derivatives
WO1996040981A1 (en) * 1995-06-07 1996-12-19 Bayer Aktiengesellschaft Testing device for determining the susceptibility of microorganisms to inhibitory agents
DE19546249A1 (en) * 1995-12-12 1997-06-19 Bayer Ag New crystal modification of 1-cyclopropyl-7 - ([S, S] -2,8-diazabicyclo [4,3,0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4 -oxo-3-quinoline carboxylic acid hydrochloride (CDCH), process for its preparation and pharmaceutical preparations containing it
DE19652239A1 (en) * 1996-12-16 1998-06-18 Bayer Ag Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -quinolone and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the associated gastroduodenal diseases
DE19735198A1 (en) * 1997-08-14 1999-02-18 Bayer Ag Optical resolution of cis- or trans-pyrrolo:piperidine derivatives
DE59804823D1 (en) * 1997-09-25 2002-08-22 Bayer Ag DRUG FORMULATION WITH CONTROLLED ACTIVE SUBSTANCE RELEASE
DE19751948A1 (en) * 1997-11-24 1999-05-27 Bayer Ag Rapid preparation of 8-alkoxy-quinolone-carboxylic acid derivative antibacterial agent, e.g. gatifloxacin, in high purity
DE19821039A1 (en) * 1998-05-11 1999-11-18 Bayer Ag Production of (S,S)-8-benzyl-2,8-diazabicyclo(4.3.0)nonane useful as intermediate for antibiotic moxifloxacin
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (en) * 1998-09-30 2002-05-22 Alcon Lab Inc A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
WO2000027398A1 (en) * 1998-11-10 2000-05-18 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
RU2270695C2 (en) 1999-03-17 2006-02-27 Дайити Фармасьютикал Ко., Лтд. Pharmaceutical composition
DE19927412A1 (en) * 1999-06-16 2000-12-21 Bayer Ag Process for the enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane
DE19931115A1 (en) 1999-07-06 2001-01-11 Bayer Ag Racemization of R, S-dioxo-benzylpyrrolopiperidine
DE19962470A1 (en) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Use of chemotherapy drugs
DE10226923A1 (en) * 2002-06-17 2003-12-24 Bayer Ag Process for the enantiomer enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane
ITMI20032259A1 (en) 2003-11-20 2005-05-21 Chemi Spa NEW POLYMORPHOUS OF ACID 1-CYCLOPROPYL-7- (S, S-2,8-DIAZABICLO-4.3.0-NON-8-IL) -6-FLUORO-1,4-DIIDRO-8-METOSSI-4-OXO -CHINOLIN CARBOSXYL CHLORIDRATE AND METHODS FOR ITS PREPARATION
EP1685130B1 (en) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
CN1244582C (en) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 Quinolone carboxylic acid compound and its preparation method and medical application
ES2284380B1 (en) * 2006-03-10 2008-11-01 Quimica Sintetica S.A. PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINO AND MOXIFLOXACINO CHLORHYDRATE.
DK2032521T3 (en) 2006-06-27 2010-01-25 Sandoz Ag New method of salt preparation
CA2669427A1 (en) 2006-11-13 2008-05-22 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
WO2008059521A2 (en) * 2006-11-14 2008-05-22 Msn Laboratories Limited Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
US7692015B2 (en) 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
WO2008102188A1 (en) 2007-02-22 2008-08-28 Tibor Nagy Procedure to manufacture and use beer and other types liquids treated with neodimium magnet
EP2083010A1 (en) 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (en) 2009-03-06 2012-04-20 Italiana Sint Spa SUMMARY OF (4AS, 7AS) -OTTAIDRO-1H-PIRROLO [3,4-B] PYRIDINE
EP2423211B1 (en) * 2009-04-20 2014-04-16 Kaneka Corporation Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
IT1398952B1 (en) * 2010-03-19 2013-03-28 F S I Fabbrica Italiana Sint PROCESS OF PREPARATION OF MOXIFLOXACINE AND ITS SALTS
CN101941969B (en) * 2010-09-30 2012-05-23 江苏正大丰海制药有限公司 Preparation method of moxifloxacin hydrochloride
CN102675307A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing chiral compound 8-phenethyl-2,8-diazabicyclo[4.3.0]nonane
CN102675308A (en) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 Method for preparing 8-benzyl-2,8-diazabicyclo(4.3.0) nonane
ITTO20110705A1 (en) 2011-07-29 2013-01-30 Italiana Sint Spa PROCEDURE FOR THE PREPARATION OF MOXIFLOXACINE CHLORIDRATE AND RELATED INTERMEDIATES
CN102964346B (en) * 2011-09-01 2015-04-22 中国中化股份有限公司 Preparation method of (S, S)-octahydro-6H-pyrrolo[3, 4-b]pyridine
CN103044418B (en) * 2011-10-14 2015-02-04 上海朴颐化学科技有限公司 Asymmetric synthesis method, relevant raw materials and preparation method of (S,S)-2,8-diazabicyclo[4,3,0] nonane
CN102408427B (en) * 2011-10-22 2012-12-12 浙江普洛康裕制药有限公司 Preparation method for moxifloxacin intermediate (1S, 6R)-8-benzyl-7, 9-dioxy-2, 8-diazabicyclo [4.3.0] nonane
BRPI1106900A2 (en) 2011-12-26 2013-11-05 Ems Sa SOLID PHARMACEUTICAL COMPOSITION UNDERSTANDING ANTIBOTH FAMILY OF QUINOLONES AND THE PROCESS OF OBTAINING THEM
FR2992218B1 (en) 2012-06-22 2015-01-23 Rivopharm Sa PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
CA2893534A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
CN103012452B (en) * 2012-12-25 2015-12-02 浙江新和成股份有限公司 The preparation method of a kind of Moxifloxacin and hydrochloride thereof
UA106556C2 (en) * 2013-05-13 2014-09-10 Наталья Николаевна Деркач Method of obtaining (1-cyclopropyl -6- fluoro-1,4-dihydro methoxy -8 -7 - [(4as, 7as) - oktahydro -6n- pyrrolo [3,4-pyridine bsch - 6- yl] -4-oxo-3-hinolinkarbonovoyi acid
CN103724262B (en) * 2013-12-10 2016-05-18 广东省第二人民医院 A kind of fluoquinolone silver compound and its production and use
CN104860944A (en) * 2015-06-09 2015-08-26 内蒙古东北六药集团有限公司 Production method of moxifloxacin hydrochloride
CN108872413B (en) * 2018-04-27 2021-06-08 山东齐都药业有限公司 Method for the determination of enantiomeric content in (S,S)-2,8-diazabicyclo[4,3,0]nonane
CN110627768B (en) * 2018-06-22 2021-11-09 扬子江药业集团有限公司 Preparation method of moxifloxacin degradation impurity J
CN110183445B (en) * 2019-06-28 2021-08-24 昆明学院 Synthetic method of moxifloxacin and its derivatives
RU2713932C1 (en) * 2019-10-31 2020-02-11 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Fluoroquinolone compounds based on pyridoxine derivatives, having antibacterial properties
CN112939849B (en) * 2019-12-11 2022-05-03 浙江新和成股份有限公司 (S, S) -2, 8-diazabicyclo [4.3.0] nonane intermediate and preparation method and application thereof
CN110981874A (en) * 2020-03-05 2020-04-10 北京四环生物制药有限公司 Preparation method of moxifloxacin hydrochloride
CN112409352B (en) * 2020-11-20 2022-05-24 华南理工大学 Moxifloxacin drug derivatives and preparation method and application thereof
CN112574197B (en) * 2020-12-07 2021-12-31 泰安汉威集团有限公司 Chiral purification method of compound C

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0754229B2 (en) * 1987-09-28 1995-06-07 松下冷機株式会社 refrigerator
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
FI901201A7 (en) * 1989-03-13 1990-09-14 Bristol Myers Squibb Co Antibacterial 5-substituted 1,4-dihydro-4-oxonaphthyridine-3-carboxylate derivatives and their preparation
DE3910663A1 (en) * 1989-04-03 1990-10-04 Bayer Ag 5-ALKYLCHINOLON CARBONIC ACIDS
JPH03188080A (en) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd Pyridonecarboxylic acid derivative

Also Published As

Publication number Publication date
JP2003048890A (en) 2003-02-21
NZ245640A (en) 1995-03-28
FI113771B (en) 2004-06-15
FI20020059L (en) 2002-01-11
TW209865B (en) 1993-07-21
CA2086914A1 (en) 1993-07-11
CZ289076B6 (en) 2001-10-17
CN1075499C (en) 2001-11-28
CZ396692A3 (en) 1993-08-11
SK396692A3 (en) 2002-09-10
SK2212000A3 (en) 2006-05-04
FI110943B (en) 2003-04-30
NO924978L (en) 1993-07-12
JPH05271229A (en) 1993-10-19
SK285223B6 (en) 2006-09-07
CN1043142C (en) 1999-04-28
HU9300034D0 (en) 1993-04-28
AU669502B2 (en) 1996-06-13
CA2086914C (en) 2005-03-15
CN1074218A (en) 1993-07-14
JP2003026574A (en) 2003-01-29
CN1061351C (en) 2001-01-31
FI104174B (en) 1999-11-30
JP4111431B2 (en) 2008-07-02
CN1212256A (en) 1999-03-31
SK285155B6 (en) 2006-07-07
EP0550903A1 (en) 1993-07-14
MX9207604A (en) 1993-10-01
MY115416A (en) 2003-06-30
FI104174B1 (en) 1999-11-30
FI990207A0 (en) 1999-02-03
HU219488B (en) 2001-04-28
HUT64065A (en) 1993-11-29
KR930016421A (en) 1993-08-26
NO301420B1 (en) 1997-10-27
KR100251886B1 (en) 2000-07-01
SK282971B6 (en) 2003-01-09
SK2232000A3 (en) 2006-05-04
FI990207L (en) 1999-02-03
CN1192440A (en) 1998-09-09
FI930049A7 (en) 1993-07-11
PL174853B1 (en) 1998-09-30
AU3105493A (en) 1993-07-15
FI930049A0 (en) 1993-01-07
PL297338A1 (en) 1993-09-06

Similar Documents

Publication Publication Date Title
NO924978D0 (en) CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES
NO922226D0 (en) 7-ISOINDOLINYL-QUINOLON AND NAVYTHYRIDON CARBOXYLIC ACID DERIVATIVES
NO922291D0 (en) 7-AZAISOINDOLINYL-QUINOLON AND NAVYTHYRIDONCARBOXYLIC ACID DERIVATIVES
FI943948L (en) Heterocyclic carboxylic acid derivatives
FI933260A7 (en) HETEROACETIC ACID DERIVATIVES
FI942049A7 (en) Benzofuranyl and thiophenylalkanecarboxylic acid derivatives
FI954404L (en) Phenoxyphenylacetic acid derivatives
FI945688A7 (en) Acetic acid derivatives
FI921135A7 (en) New carboxylic acid amides
FI940216A0 (en) Quinolone and naphthyridonecarboxylic acid derivatives
FI921163A7 (en) N-ACYL-A-AMINO ACID DERIVATIVES
FI934411L (en) Quinolone carboxylic acid
FI922095L (en) SUBSTITUERADE CARBOXYLIC ACID DERIVATIVES
NO930760L (en) SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
FI942976A7 (en) 5-Amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivatives
DE59305938D1 (en) Pyridyloxy-acrylic acid ester
NO930722D0 (en) IMIDAZOLYL-SUBSTITUTED PHENYLEDIC DIETIC ACID AMIDES
FI933492L (en) LIPOXIGENAS INHIBERANDE HYDROXAMINIC ACID AND N-HYDROXYUREA DERIVATIVES
DE59402621D1 (en) Fluorotrifluoromethylbenzoic acid derivatives
FI932953A7 (en) IMIDAZOLYLSUBSTITUERADE PHENYLPROPION- OCH -CINNAMIC ACID DERIVATIVES
FI930462A7 (en) AMINOBENZOIC ACID DERIVATIVES
FI933512A7 (en) 2-substituerade quinolinylmethoxyphenylacetic acid derivative
FI933300L (en) FOERFARANDE FOER RENGOERING AV CHLORINEETIC ACID I GASFORM
FI941064A7 (en) Acyloxyhexanoic acid derivatives
FI933307L (en) ANTI-INFLAMMATORY INDOLINYL-N-HYDROXIUREA AND INDOLINYL-N-HYDROXAMIC ACID DERIVATIVES

Legal Events

Date Code Title Description
MK1K Patent expired